2019
DOI: 10.1002/elan.201900041
|View full text |Cite
|
Sign up to set email alerts
|

Studies on the Affinity‐based Biosensors for Electrochemical Detection of HER2 Cancer Biomarker

Abstract: As cancer diseases are the second main cause of death it is necessary to elaborate fast and efficient early diagnosis methods for their detection. One of the possibilities is the analysis of protein biomarkers, which abnormal concentration in physiological fluids might be an indication of cancer disease progression. Herein, we present the studies on the development of affinity‐based biosensors for electrochemical detection of HER2 protein, which is a common biomarker of breast cancer. The main objective was to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 49 publications
0
5
0
Order By: Relevance
“…Antibody-HER2-MB-labelled aptamer.-The possibility of formation of a stable antibody-based receptor layer for HER2 detection was previously shown in our group, 37 however such a monolayer did not allow for HER2 determination within a 1-100 ng•ml −1 concentration range. Therefore we applied a secondary antibody that was further conjugated with HRP enzyme, which catalyzed the oxidation of TMB substrate that was analyzed using amperometry technique.…”
Section: Resultsmentioning
confidence: 90%
See 2 more Smart Citations
“…Antibody-HER2-MB-labelled aptamer.-The possibility of formation of a stable antibody-based receptor layer for HER2 detection was previously shown in our group, 37 however such a monolayer did not allow for HER2 determination within a 1-100 ng•ml −1 concentration range. Therefore we applied a secondary antibody that was further conjugated with HRP enzyme, which catalyzed the oxidation of TMB substrate that was analyzed using amperometry technique.…”
Section: Resultsmentioning
confidence: 90%
“…36 Herein, we present the electrochemical studies on the interaction of affinity-based receptor layers with HER2 protein. It is a direct continuation of our previous research presented in 37 where we focused on the development of antibody sandwich layer for the analysis of HER2 biomarker. Firstly, we tested a hybrid construct consisting of antibodies and aptamer specific for HER2 biomarker that served either as a capture or reporter element (Schemes 1a and 1b).…”
mentioning
confidence: 73%
See 1 more Smart Citation
“…Of these papers, about half focused on human epidermal growth factor receptor 2 (HER2; Table ). Biosensors were also developed for several other breast cancer biomarkers (or general cancer biomarkers assessed in breast cancer cells), which include miR-16 in MCF-7 cells (LOD, 16 fM), miR-21 (LOD, 0.1 fM), anterior gradient protein 2 homologue, extracellular vesicles, nucleolin (LODs, 6–8 cells/mL), ,,, CD44, platelet derived growth factor receptor beta, CA15-3 (LOD, 0.11 U/mL), and mucin 1 (LODs, 0.031 fM, 25 cells/mL, 0.25 pM, and 3.0 × 10 5 particles/μL). , …”
Section: Aptamersmentioning
confidence: 99%
“…For example, the biopsy is highly invasive and allows only a small part of a tissue to be analyzed. MRI and mammography also have disadvantages, such as the requirement for sophisticated equipment and inducing radiation doses in sensitive tissue (breast) 7 , 8 . One solution is the analysis of cancer biomarkers found in physiological fluids such as blood 9 12 .…”
Section: Introductionmentioning
confidence: 99%